|
|
Latest news for Resources
|
Pertuzumab Plus Trastuzumab and Docetaxel Will Become Decision Resources? Proprietary Clinical Gold-Standard Treatment ...
Decision Resources, one of the world?s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on clinical data and the opinions of interviewed thought leaders, Roche/Genentech/Chugai?s pertuzumab plus trastuzumab and docetaxel will become Decision Resources? proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer ...
Zone Resources Inc. Grants Incentive Stock Options
VANCOUVER, BRITISH COLUMBIA-- - Zone Resources Inc. announces that pursuant to its stock option plan, the Company has granted incentive stock options to its directors, officers, consultants, and employees to purchase in the total of 75,000 common shares in the capital stock of the company, subject to ...
EXCO Resources Announces Agreement Granting an Exclusivity Period to an Unaffiliated Private Investor for a Potential ...
EXCO Resources, Inc. today announced that it has entered into an agreement granting a forty-five day exclusivity period to an unaffiliated private infrastructure fund to negotiate the sale of a one-third equity interest in TGGT Holdings, LLC.
Harvest Natural Resources Updates Drilling Operations - Qarn Alam Block 64, Oman
HOUSTON, Feb. 3, 2012 /PRNewswire/ -- Harvest Natural Resources, Inc. (NYSE: HNR - News) announced today that the Al Ghubar North-1 (AGN-1) exploration well onshore Oman has reached a total depth (TD) of 10,482 ...
Lundin Mining Acquires 15.4% Interest in Salazar Resources
VANCOUVER, BRITISH COLUMBIA-- - Salazar Resources Ltd. is pleased to announce that the Company has closed a non-brokered private placement consisting of 6,000,000 units at a price of $0.50 per Unit for gross proceeds of $3 million. Each Unit comprises one common share and one-half of one non-transferable ...
|
Writen by:
|
|
|
